Effects of the neurotoxin 3,3'-iminodipropionitrile on acoustic startle and locomotor activity in rats: A comparison of functional observational and automated startle assessment methods

Neurotoxicology and Teratology

Volumn 20, Issue 2, 1998, Pages 203-211

  Fukumura, Masao ^a   Sethi, Neil ^a   Vorhees, Charles V ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

3,3' Iminodipropionitrile (IDPN); Acoustic startle; Locomotor activity; Rat

Indexed keywords

3,3' IMINODIPROPIONITRILE;

ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; CONTROLLED STUDY; DISEASE MARKER; DYSKINESIA; ENVIRONMENTAL MONITORING; ENVIRONMENTAL PROTECTION; LOCOMOTION; MALE; NERVOUS SYSTEM FUNCTION; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NONHUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; RAT; SCREENING TEST; STARTLE REFLEX; TOXICOLOGICAL PARAMETERS;

ANIMALS; MALE; MOTOR ACTIVITY; NEUROTOXINS; NITRILES; RATS; STARTLE REACTION; TOXICITY TESTS;

ANIMALIA;

EID: 0031966095     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(97)00100-1     Document Type: Article

References (26)

1. Broxup B., Robinson K., Losos G., Beyrouty P. Correlation between behavioral and pathlogical changes in the evaluation of neurotoxicity. Toxicol. Appl. Pharmacol. 101:1989;510-520.
2. Buelke-Sam J., Kimmel C. A., Adams J. Design considerations in screening for behavioral teratogens. Results of the collaborative behavioral teratology study Neurobehav. Toxicol. Teratol. 7:1985;537-790.
3. Cadet J. L. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome. Behavioral and biochemical pharmacology Neurosci. Biobehav. Rev. 13:1989;39-45.
4. Chou S., Hartman H. A. Axonal lesions and waltzing syndrome after IDPN administration in rats with a concept - axostasis. Acta Neuropathol. (Berl.). 3:1964;428-450.
5. Clark A. W., Griffin J. W., Price D. L. The axonal pathology in chronic IDPN intoxication. J. Neuropathol. Exp. Neurol. 39:1980;42-55.
6. Crofton K. M., Janssen R., Prazma J., Pulver S., Barone S. Jr. The ototoxicity of 3,3′-iminodipropionitrile. Functional and morphological evidence of cochlear damage Hear. Res. 80:1994;129-140.
7. Crofton K. M., Knight T. Auditory deficits and motor dysfunction following iminodipropionitrile administration in the rat. Neurotoxicol. Teratol. 13:1991;575-581.
8. Davis M. The mammalian startle response. Eaton R. C. Neural mechanisms of startle behavior. 1984;287-351 Plenum Press, New York.
9. Genter M. B., Llorens J., O'Callaghan J. P., Peele D. B., Morgan K. T., Crofton K. M. Olfactory toxicity of beta,beta′-iminodipropionitrile in the rat. J. Pharmacol. Exp. Ther. 263:1992;1432-1439.
10. Irwin S. Comprehensive observational assessment. Ia. A systematic, quantitative procedure for assessing the behavioral and physiological state of the mouse Psychopharmacologia. 13:1968;222-257.
11. Ivens I. Neurotoxicity testing during long-term studies. Neurotoxicol. Teratol. 12:1990;637-641.
12. Llorens J., Dememes D. Hair cell degeneration resulting from 3,3′-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells. Hear. Res. 76:1994;78-86.
13. Llorens J., Dememes D. Hair cell degeneration resulting from 3,3′-iminodipropionitrile toxicity in the rat vestibular epithelia. Hear. Res. 76:1994;78-86.
14. Llorens J., Dememes D., Sans A. The behavioral syndrome caused by 3,3′-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells. Toxicol. Appl. Pharmacol. 123:1993;199-210.
15. Moser V. C. Approaches for assessing the validity of a functional observational battery. Neurotoxicol. Teratol. 12:1990;483-488.
16. Moser V. C. Investigations of amitraz neurotoxicity in rats. IV. Assessment of toxicity syndrome using a functional observational battery. Fundam. Appl. Toxicol. 17:1991;7-16.
17. Moser V. C., Boyes W. K. Prolonged neurobehavioral and visual effects of short-term exposure to 3,3′-iminodipropionitrile (IDPN) in rats. Fundam. Appl. Toxicol. 21:1993;277-290.
18. Moser V. C., Cheek B. M., MacPhail R. C. A multidisciplinary approach to toxicological screening. III. Neurobehavioral toxicity J. Toxicol. Environ. Health. 45:1995;173-210.
19. Moser V. C., MacPhail R. C. Comparative sensitivity of neurobehavioral tests for chemical screening. Neurotoxicology. 11:1990;335-344.
20. Moser V. C., MacPhail R. C. International validation of a neurobehavioral screening battery. The IPCS/WHO collaborative study Toxicol. Lett. 64-65:1992;217-223.
21. Moser V. C., McDaniel K. L., Phillips P. M. Rat strain and stock comparisons using a functional observational battery. Baseline values and effects of amitraz Toxicol. Appl. Pharmacol. 108:1991;267-283.
22. Schulze G. E., Boysen B. G. A neurotoxicity screening battery for use in safety evaluation. Effects of acrylamide and 3′,3′-iminodipropionitrile Fundam. Appl. Toxicol. 16:1991;602-615.
23. U.S.Environmental Protection Agency Toxic substances control act testing guidelines605. Fed. Reg. , 40:1985;50. 39458-39460.
24. U.S.Environmental Protection Agency.: Revised neurotoxicity testing guidelines. Natl. Tech. Info. Serv. PB 91-154617; 1991.
25. Vorhees C. V., Butcher R. E., Brunner R. L., Sobotka T. J. A developmental test battery for neurobehavioral toxicity in rats. A preliminary analysis using monosodium glutamate, calcium carrageenan and hydroxyurea Toxicol. Appl. Pharmacol. 50:1979;267-282.
26. Wolff G., Kunze E., Rodden A., Oepen H. Loss of auditory startle-reflex in the iminodipropionitrile (IDPN) treated rat. Life Sci. 20:1977;1163-1166.